Precision Medicine

Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.

Including informal caregivers in discharge planning can cut readmissions by 25%

When caregivers are included in the discharge of elderly patients, readmission rates can be reduced by 25 percent, according to a study published in the Journal of the American Geriatrics Society.

Embryo screening technology remains outdated, while continued research faces controversy

Individuals interested in vitro fertilization (IVF) often depend on pre-implantation genetic screening (PGS) to ensure an embryo is able to grow into a healthy child. But a study recently published in EMBO Reports found these screenings are often unreliable in identifying between unhealthy and healthy embryos.

Group sequential designs produce reliable results in preclinical trials

Researchers from Charité-Universitätsmedizin Berlin and the Berlin Institute of Health (BIH) have developed a more flexible study design to improve the efficiency of preclinical research, publishing their findings in PLOS Biology.

Thumbnail

ACHE 2017: Embracing value-based care essential to attracting big purchasers like Boeing, Walgreens

Large corporations want healthy workers and lower healthcare costs. If hospitals and medical groups are going to win the right to provide care to those employees and their families, innovative approaches to care, having the right infrastructure in place and taking a lot of meetings are a must. 

Possible sepsis treatment needs additional evidence

Paul Marik, MD, an intensive care surgeon at the Eastern Virginia Medical School in Norfolk, claims he has been able to treat sepsis, the leading cause of death for patients in the hospital, in 150 patients with only one fatality.

Novartis completes FDA application for 'cancer-killing' technology

The race to produce the first CAR-T, a technology capable of reprograming a cancer patient's white blood cells to kill tumor cells, has reached its next phase, thanks to Novartis. In Forbes, Samuele Butera, the Global Business Leader for Cell & Gene Therapies at Novartis, explains the company’s work in fighting cancer within the body.

Thumbnail

Software identifies cause of ischemic stroke

Identifying the cause of an ischemic stroke is crucial in preventing a second stroke, but physicians lack the tools to make such a determination. Researchers from Massachusetts General Hospital (MGH) and the MGH Stroke Service have developed software capable of pinpointing such causes.

Virtual reality reduces pain in hospitalized patients

3D virtual reality (VR) technology is for more than just video games. In a study published in The Journal of Medical Internet Research Mental Health found VR headsets effective in reducing a patient's pain after only 15 minute.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup